Lexicon Pharmaceuticals
LXRX
#6608
Rank
โ‚น61.63 B
Marketcap
โ‚น145.47
Share price
-3.70%
Change (1 day)
366.75%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -โ‚น5.92 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น70.86 Million. In 2024 the company made an earning of -โ‚น18.69 Billion a decrease over its 2023 earnings that were of -โ‚น16.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น5.92 Billion-68.35%
2024 -โ‚น18.69 Billion13.15%
2023 -โ‚น16.52 Billion73.74%
2022 -โ‚น9.51 Billion16.16%
2021 -โ‚น8.19 Billion49.82%
2020 -โ‚น5.47 Billion-147.19%
2019 โ‚น11.57 B-203.42%
2018 -โ‚น11.2 Billion-15.31%
2017 -โ‚น13.22 Billion0.2%
2016 -โ‚น13.19 Billion2920.7%
2015 -โ‚น0.44 Billion-95.33%
2014 -โ‚น9.36 Billion-3.61%
2013 -โ‚น9.71 Billion-5.52%
2012 -โ‚น10.28 Billion-4.17%
2011 -โ‚น10.73 Billion15.5%
2010 -โ‚น9.29 Billion8.36%
2009 -โ‚น8.57 Billion-4.81%
2008 -โ‚น9.01 Billion28.79%
2007 -โ‚น6.99 Billion35.71%
2006 -โ‚น5.16 Billion52.91%
2005 -โ‚น3.37 Billion-23.89%
2004 -โ‚น4.43 Billion-24.19%
2003 -โ‚น5.84 Billion-0.48%
2002 -โ‚น5.87 Billion44.12%
2001 -โ‚น4.07 Billion23.01%
2000 -โ‚น3.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น661.71 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น92.78 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น487.77 B-7,727.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น48.37 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น6.22 B-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.56 Billion-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.17 Billion-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น63.34 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.89 Billion-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA